Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 12 studies | 35% ± 20% | |
myofibroblast cell | 6 studies | 35% ± 14% | |
fibroblast | 4 studies | 25% ± 7% | |
smooth muscle cell | 3 studies | 19% ± 3% |
Insufficient scRNA-seq data for expression of SCARA3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 5382.37 | 2548 / 2642 | 99% | 222.69 | 701 / 705 |
thymus | 100% | 8886.37 | 650 / 653 | 87% | 160.05 | 526 / 605 |
ovary | 77% | 1988.41 | 139 / 180 | 98% | 169.15 | 420 / 430 |
uterus | 100% | 12937.77 | 170 / 170 | 71% | 56.17 | 325 / 459 |
prostate | 100% | 4281.25 | 244 / 245 | 62% | 22.50 | 312 / 502 |
breast | 83% | 2571.40 | 383 / 459 | 75% | 41.13 | 843 / 1118 |
esophagus | 99% | 4948.61 | 1431 / 1445 | 58% | 30.39 | 107 / 183 |
bladder | 100% | 4691.05 | 21 / 21 | 41% | 19.33 | 208 / 504 |
lung | 91% | 2419.04 | 524 / 578 | 49% | 18.61 | 567 / 1155 |
skin | 97% | 2777.18 | 1751 / 1809 | 13% | 5.46 | 62 / 472 |
blood vessel | 100% | 9880.89 | 1330 / 1335 | 0% | 0 | 0 / 0 |
intestine | 84% | 3427.91 | 813 / 966 | 14% | 5.84 | 75 / 527 |
adipose | 88% | 3721.03 | 1060 / 1204 | 0% | 0 | 0 / 0 |
kidney | 38% | 982.61 | 34 / 89 | 41% | 37.90 | 366 / 901 |
stomach | 53% | 1737.34 | 192 / 359 | 24% | 9.71 | 68 / 286 |
pancreas | 5% | 76.69 | 17 / 328 | 69% | 26.71 | 123 / 178 |
adrenal gland | 51% | 824.66 | 131 / 258 | 23% | 7.71 | 54 / 230 |
tonsil | 0% | 0 | 0 / 0 | 58% | 23.70 | 26 / 45 |
eye | 0% | 0 | 0 / 0 | 53% | 21.07 | 42 / 80 |
heart | 38% | 777.83 | 328 / 861 | 0% | 0 | 0 / 0 |
liver | 1% | 16.80 | 3 / 226 | 30% | 11.53 | 123 / 406 |
lymph node | 0% | 0 | 0 / 0 | 31% | 9.22 | 9 / 29 |
muscle | 4% | 59.24 | 29 / 803 | 0% | 0 | 0 / 0 |
spleen | 2% | 23.94 | 5 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.16 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0034138 | Biological process | toll-like receptor 3 signaling pathway |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0006979 | Biological process | response to oxidative stress |
GO_0009650 | Biological process | UV protection |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005581 | Cellular component | collagen trimer |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
GO_0005044 | Molecular function | scavenger receptor activity |
Gene name | SCARA3 |
Protein name | Scavenger receptor class A member 3 (Cellular stress response gene protein) |
Synonyms | CSR |
Description | FUNCTION: Seems to protect cells by scavenging oxidative molecules or harmful products of oxidation. . |
Accessions | ENST00000301904.4 [Q6AZY7-1] ENST00000337221.8 [Q6AZY7-2] Q6AZY7 |